0000950103-18-008190.txt : 20180702
0000950103-18-008190.hdr.sgml : 20180702
20180702214618
ACCESSION NUMBER: 0000950103-18-008190
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180702
FILED AS OF DATE: 20180702
DATE AS OF CHANGE: 20180702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shire Human Genetic Therapies, Inc.
CENTRAL INDEX KEY: 0001745009
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38550
FILM NUMBER: 18934614
BUSINESS ADDRESS:
STREET 1: 300 SHIRE WAY
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: (617) 588-8119
MAIL ADDRESS:
STREET 1: 300 SHIRE WAY
CITY: LEXINGTON
STATE: MA
ZIP: 02421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shire plc
CENTRAL INDEX KEY: 0000936402
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38550
FILM NUMBER: 18934615
BUSINESS ADDRESS:
STREET 1: BLOCK 2, MIESIAN PLAZA
STREET 2: 50-58 BAGGOT STREET LOWER
CITY: DUBLIN 2
STATE: L2
ZIP: D02 HW68
BUSINESS PHONE: 353-1-609-6000
MAIL ADDRESS:
STREET 1: BLOCK 2, MIESIAN PLAZA
STREET 2: 50-58 BAGGOT STREET LOWER
CITY: DUBLIN 2
STATE: L2
ZIP: D02 HW68
FORMER NAME:
FORMER CONFORMED NAME: Shire Ltd.
DATE OF NAME CHANGE: 20080523
FORMER NAME:
FORMER CONFORMED NAME: Shire plc
DATE OF NAME CHANGE: 20051125
FORMER NAME:
FORMER CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC
DATE OF NAME CHANGE: 19980302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Translate Bio, Inc.
CENTRAL INDEX KEY: 0001693415
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 611807780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-945-7361
MAIL ADDRESS:
STREET 1: 29 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: RaNA Therapeutics, Inc.
DATE OF NAME CHANGE: 20161228
4
1
dp93048_4.xml
FORM 4
X0306
4
2018-07-02
0
0001693415
Translate Bio, Inc.
TBIO
0001745009
Shire Human Genetic Therapies, Inc.
300 SHIRE WAY
LEXINGTON
MA
02421
0
0
1
0
0000936402
Shire plc
BLOCK 2, MIESIAN PLAZA
50-58 BAGGOT STREET LOWER
DUBLIN 2
L2
D02 HW68
IRELAND
0
0
1
0
Common Stock
2018-07-02
4
J
0
183619
0
A
7078945
D
These shares were issued upon the closing of the Issuer's initial public offering in satisfaction of contractual obligations, based on the initial public offering price of $13.00 per share, without payment of any additional consideration by Shire Human Genetic Therapies, Inc. at the time of issuance.
These shares are owned directly by Shire Human Genetic Therapies, Inc., which is an indirect wholly owned subsidiary of Shire plc. Shire plc is an indirect beneficial owner of the reported securities.
/s/ Jeffrey Prowda
2018-07-02